Mediators of inflammation
The most recent articles from:
Mediators Inflamm.
-
Mediators of inflammation · Jan 2013
Multicenter StudyUsefulness of adalimumab in the treatment of refractory uveitis associated with juvenile idiopathic arthritis.
To assess the efficacy and safety of adalimumab in patients with juvenile idiopathic arthritis (JIA) and associated refractory uveitis. ⋯ Adalimumab seems to be an effective and safe treatment for JIA-associated refractory uveitis and may reduce steroid requirement.